Chidamide Clinical Trials
25 recruitingDrug
Phase 221Phase 16Not Applicable2Phase 32
Showing 1–20 of 25 trials
Recruiting
Phase 2
Chidamide Combination With R-mini CHOP Followed by Chidamide+CD20 Maintenance in Elderly Newly Diagnosed MYC/BCL2+ DLBCL
Diffuse Large B-Cell Lymphoma (DLBCL)
Ou Bai, MD/PHD50 enrolled1 locationNCT07493148
Recruiting
Phase 3
Chidamide for Maintenance Treatment of HBV-infected Diffuse DLBCL in Patients Initially Treated With R-CHOP
Diffuse Large B-Cell Lymphoma (DLBCL)
Ou Bai, MD/PHD200 enrolled1 locationNCT07493109
Recruiting
Phase 2
PD-1 Antibody-based Therapy With Concurrent RT for Early-stage NKTCL
Natural Killer/T-cell Lymphoma
Ruijin Hospital47 enrolled1 locationNCT07380984
Recruiting
Phase 2
CRP Regimen in Treating Elderly Patients With Previously Untreated Double-Positive DLBCL
Diffuse Large B-Cell Lymphoma (DLBCL)
Tianjin Medical University Cancer Institute and Hospital58 enrolled1 locationNCT07397832
Recruiting
Phase 2
QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic Cancer
Metastatic Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital33 enrolled1 locationNCT06951997
Recruiting
Phase 1Phase 2
Golidocitinib Combined With Mitoxantrone Hydrochloride Liposome or Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma
Peripheral T Cell Lymphoma
Sun Yat-sen University101 enrolled1 locationNCT07093710
Recruiting
Phase 2
Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML
AML (Acute Myeloid Leukemia)Allogeneic Hematopoietic Cell Transplantation (HCT)
Institute of Hematology & Blood Diseases Hospital, China134 enrolled5 locationsNCT07304232
Recruiting
Phase 2
Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia
Newly DiagnosedAcute Monocytic Leukemia
The First Affiliated Hospital of Soochow University92 enrolled1 locationNCT05566054
Recruiting
Phase 2
Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML
Acute Myeloid Leukemia
Guangdong Provincial People's Hospital240 enrolled13 locationsNCT06451861
Recruiting
Phase 3
A Phase 3 Multinational Study of Golidocitinib Versus Investigator's Choice in r/r PTCL (JACKPOT19)
Dizal Pharmaceuticals218 enrolled50 locationsNCT07234162
Recruiting
Phase 1Phase 2
Single Arm Study of Post-transplant Azacitidine and Chidamide for Prevention of Acute Myelogenous Leukemia Relapse
Leukemia, Myeloid, Acute
Zhujiang Hospital20 enrolled1 locationNCT05270200
Recruiting
Phase 2
Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients
Adult T-cell Leukemia/Lymphoma
The First Affiliated Hospital of Soochow University27 enrolled1 locationNCT07159620
Recruiting
Not Applicable
Chidamide, Venetoclax, and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia
Acute Myeloid LeukemiaAML
Institute of Hematology & Blood Diseases Hospital, China184 enrolled1 locationNCT06386302
Recruiting
Phase 2
Glofitamab Combination With Chidamide in Patients With Recurrent/Refractory DLBCL
Tianjin Medical University Cancer Institute and Hospital22 enrolled1 locationNCT06570447
Recruiting
Phase 2
Chidamide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (R/R PTCL)
Relapsed or Refractory Peripheral T-cell Lymphoma
Great Novel Therapeutics Biotech & Medicals Corporation33 enrolled5 locationsNCT05833724
Recruiting
Phase 2
Chidamide in Combination With Azacitidine, Liposomal Mitoxantrone, and Prednisone (CAMP Regimen) for the Treatment of Previously Untreated Nodal TFH Cell Lymphoma
Peripheral T Cell LymphomaEpigenetic Repression
Institute of Hematology & Blood Diseases Hospital, China37 enrolled1 locationNCT05958719
Recruiting
Phase 2
Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment Exhaustion
Solid TumorPrecision Medicine
Tianjin Medical University Second Hospital300 enrolled1 locationNCT06739395
Recruiting
Phase 2
Safety and Efficacy of Fruquintinib Plus Chidamide and Sintilimab in the Third and Later Line Treatment of MSS/pMMR Metastatic Colorectal Cancer
Colorectal Cancer Metastatic
Dai, Guanghai46 enrolled1 locationNCT06685276
Recruiting
Phase 1Phase 2
Chidamide Bridging for CAR-T Therapy
Non-Hodgkin's Lymphoma
Chinese PLA General Hospital120 enrolled13 locationsNCT05370547
Recruiting
Phase 1Phase 2
APG-1252 Monotherapy or in Combination With Other Therapeutic Agent in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma
NHL, Adult
Ascentage Pharma Group Inc.51 enrolled4 locationsNCT05186012